Liesbeth de Vries

View Scopus Profile

If you made any changes in Pure these will be visible here soon.

89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
Broer, L. N., Knapen, D. G., Suurs, F. V., Moen, I., Giesen, D., Waaijer, S. J. H., Indrevoll, B., Ellingsen, C., Kristian, A., Cuthbertson, A. S., de Groot, D-J. A., Cole, P. E., de Vries, E. G. E., Hagemann, U. B. & Lub-de Hooge, M. N., 14-Apr-2022, (E-pub ahead of print) In: The Journal of Nuclear Medicine.
Research output: Contribution to journal › Article › Academic › peer-review
⁸⁹Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
Kok, I. C., Hooiveld, J. A., van de Donk, P. P., Giesen, D., van der Veen, E. L., Lub-de Hooge, M. N., Brouwers, A. H., Hiltermann, T. J. N., van der Wekken, A. J., Hijmering-Kappelle, L. B. M., Timens, W., Elias, S. G., Hospers, G. A. P., Groen, H. J. M., Uyterlinde, W., van der Hiel, B., Haanen, J. B., de Groot, D. J. A., Jalving, M. & de Vries, E. G. E., Jan-2022, In: Annals of Oncology. 33, 1, p. 80-88 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

22 Citations (Scopus)

39 Downloads (Pure)
⁸⁹Zr-PET imaging to predict tumor uptake of ¹⁷⁷Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma
Giesen, D., Lub-de Hooge, M. N., Nijland, M., Heyerdahl, H., Dahle, J., de Vries, E. G. E. & Pool, M., Dec-2022, In: Scientific Reports. 12, 10 p., 6286.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

1 Citation (Scopus)

14 Downloads (Pure)
Abstract CT207: A phase 1 open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a Trispecific Humabody® T-cell enhancer, in patients with PSMA+ advanced and/or metastatic solid tumors (POTENTIA)
de Bono, J. S., Arkenau, H-T., Gort, E. H., Devriese, L. L., Fontana, E., Knapen, D. G., Tiu, C., Williams, A., de Groot, D. J. A., Gunaydin, U. M., Bartlett, P., Pierce, A. J., Bland-Ward, P., Hashimoto, K. & de Vries, E. G. E., 1-Jun-2022, In: Cancer Research. 82, 12_Supplement, p. CT207-CT207
Research output: Contribution to journal › Meeting Abstract › Academic
Cancer Medicines: What Is Essential and Affordable in India?
Sengar, M., Fundytus, A., Hopman, W., Pramesh, C. S., Radhakrishnan, V., Ganesan, P., Mathew, A., Lombe, D., Jalink, M., Gyawali, B., Trapani, D., Roitberg, F., De Vries, E. G. E., Moja, L., Ilbawi, A., Sullivan, R. & Booth, C. M., 19-Jul-2022, In: JCO global oncology. 8, 12 p., e2200060.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

1 Citation (Scopus)

58 Downloads (Pure)

134 Supervision and examination of PhD students of the UG
58 Professional or public presentation
4 Academic presentation

Neuro-endocriene tumoren
Liesbeth de Vries (Invited speaker)
20-Jan-2023
Activity: Talk and presentation › Professional or public presentation › Professional
Latest imaging advances in PET and beyond translated to bladder and kidney cancers
Liesbeth de Vries (Invited speaker)
12-Sep-2022
Activity: Talk and presentation › Professional or public presentation › Professional
Seeing the light with molecular imaging for systemic cancer treatment decisions
Liesbeth de Vries (Invited speaker)
12-Jun-2022
Activity: Talk and presentation › Professional or public presentation › Professional
Molecular imaging of immunotherapy and CD8
Liesbeth de Vries (Invited speaker)
8-Dec-2022
Activity: Talk and presentation › Professional or public presentation › Professional
Immunotherapy and Information of Molecular Imaging
Liesbeth de Vries (Invited speaker)
21-Mar-2022
Activity: Talk and presentation › Professional or public presentation › Professional

Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Nienhuis, H. (Contributor), Van Leeuwen-Stok, E. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), Qiu, S. (Contributor), Van Deurzen, C. H. M. (Contributor), Timmer-Bosscha, H. (Contributor), de Vries, L. (Contributor), Walenkamp-Hageman, A. (Contributor) & Schröder, C. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004491.v1, https://doi.org/10.6084%2Fm9.figshare.12004491.v1
Dataset
Data to: Evidence Based Selection of Housekeeping Genes
de Jonge, H. (Creator), Fehrmann, R. (Creator), de Bont, E. (Creator), Hofstra, R. M. W. (Creator), Gerbens, F. (Creator), Kamps, W. (Creator), de Vries, L. (Creator), van der Zee, A. (Creator), te Meerman, G. (Creator) & ter Elst, A. (Creator), University of Groningen, 19-Sep-2007
https://figshare.com/articles/Evidence_Based_Selection_of_Housekeeping_Genes/151673
Dataset
Additional file 6 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Timmer-Bosscha, H. (Contributor), Van Deurzen, C. H. M. (Contributor), Van Leeuwen-Stok, E. (Contributor), van der Vegt, B. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Qiu, S. (Contributor), Schröder, C. (Contributor), de Vries, L. (Contributor) & Walenkamp-Hageman, A. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004500.v1, https://doi.org/10.6084%2Fm9.figshare.12004500.v1
Dataset
Additional file 7 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Schröder, C. (Contributor), van Rooijen, J. (Contributor), Walenkamp-Hageman, A. (Contributor), Van Deurzen, C. H. M. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Timmer-Bosscha, H. (Contributor), van der Vegt, B. (Contributor) & Van Leeuwen-Stok, E. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004506.v1, https://doi.org/10.6084%2Fm9.figshare.12004506.v1
Dataset
Additional file 5 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Van Deurzen, C. H. M. (Contributor), Walenkamp-Hageman, A. (Contributor), Nienhuis, H. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), van Rooijen, J. (Contributor), Van Leeuwen-Stok, E. (Contributor), Schröder, C. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor) & Timmer-Bosscha, H. (Contributor), University of Groningen, 31-Mar-2020
DOI: 10.6084/m9.figshare.12004494.v1, https://doi.org/10.6084%2Fm9.figshare.12004494.v1
Dataset

Vaccinatie tegen coronavirus werkt goed tijdens behandeling van solide tumoren
Liesbeth de Vries
04/10/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular
Der Corona-Impfstoff wirkt gut bei der Behandlung von soliden Tumoren
Liesbeth de Vries
23/09/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular
Tijdens behandeling van solide tumoren werkt het coronavaccin goed
Liesbeth de Vries
22/09/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular
Coronavaccinatie werkt goed tijdens tumorbehandeling
Liesbeth de Vries
21/09/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular
De coronavaccins zijn veilig en goed werkzaam bij kankerpatiënten die chemotherapie of immuuntherapie krijgen, blijkt uit onderzoek van onder meer het Universitair Medisch Centrum Groningen
Liesbeth de Vries
21/09/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular

Liesbeth de Vries

Network

Dive into details

89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice

⁸⁹Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

⁸⁹Zr-PET imaging to predict tumor uptake of ¹⁷⁷Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma

Abstract CT207: A phase 1 open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a Trispecific Humabody® T-cell enhancer, in patients with PSMA+ advanced and/or metastatic solid tumors (POTENTIA)

Cancer Medicines: What Is Essential and Affordable in India?

Neuro-endocriene tumoren

Latest imaging advances in PET and beyond translated to bladder and kidney cancers

Seeing the light with molecular imaging for systemic cancer treatment decisions

Molecular imaging of immunotherapy and CD8

Immunotherapy and Information of Molecular Imaging

Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Data to: Evidence Based Selection of Housekeeping Genes

Additional file 6 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Additional file 7 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Additional file 5 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Vaccinatie tegen coronavirus werkt goed tijdens behandeling van solide tumoren

Der Corona-Impfstoff wirkt gut bei der Behandlung von soliden Tumoren

Tijdens behandeling van solide tumoren werkt het coronavaccin goed

Coronavaccinatie werkt goed tijdens tumorbehandeling

De coronavaccins zijn veilig en goed werkzaam bij kankerpatiënten die chemotherapie of immuuntherapie krijgen, blijkt uit onderzoek van onder meer het Universitair Medisch Centrum Groningen

Liesbeth de Vries

Network

Research output

Activities

Datasets

Press / Media